Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

Rhea-AI Summary

Eton Pharmaceuticals, Inc. (Nasdaq: ETON) to report second quarter 2023 financial results on August 10, 2023. The company will host a conference call and live audio webcast to discuss the results. Management will take live questions and address emailed questions from investors. The webcast can be accessed on the Investors section of Eton’s website.

DEER PARK, Ill., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2023 financial results on Thursday, August 10, 2023. Management will host a conference call and live audio webcast to discuss these results at 4:30 p.m. ET (3:30 p.m. CT).

Register* (Audio Only) Click here

In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.

The live webcast can be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.

* Conference call participants should register to obtain their dial-in and passcode details. Please be sure to register using a valid email address.

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has three FDA-approved products in ALKINDI SPRINKLE®, Carglumic Acid tablets, and Betaine Anhydrous for oral solution, and four late-stage pipeline candidates under development with dehydrated alcohol injection, ZENEO® hydrocortisone autoinjector, ET-400, and ET-600. In addition, the Company receives royalties and is entitled to receive milestone payments on other products. For more information, please visit our website at www.etonpharma.com.

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals

FAQ

When will Eton Pharmaceuticals report second quarter 2023 financial results?

Eton Pharmaceuticals will report the results on Thursday, August 10, 2023.

How can investors access the live audio webcast of the results discussion?

Investors can access the live webcast on the Investors section of Eton’s website at https://ir.etonpharma.com/.

How can investors submit questions for the conference call?

Investors can email questions to: investorrelations@etonpharma.com.

Will the webcast be available for later viewing?

An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.